Results 111 to 120 of about 1,009 (151)

Special Issue "Dendritic Cell and Cancer Therapy 2.0". [PDF]

Int J Mol Sci
Zanotta S, Galati D.
europepmc   +1 more source

Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China. [PDF]

Acta Derm Venereol
Li S, Zou J, Chen R, Zhang L.
europepmc   +1 more source

Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Ann Hematol
Lee BJ.
europepmc   +1 more source

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council. [PDF]

Cancers (Basel)
Bakshi N, Al Hejazi A, Al-Maghraby H, Al Mugairi A, Alotaibi AS, Khogeer H, Seliem RM, Pandita R, Raslan H, Aung PP, Ohgami RS.   +10 more
europepmc   +1 more source

Case Report: A rare <i>RUNX1</i> rearrangement resulting from t(8;21)(p12;q22) in acute myeloid leukemia with plasmacytoid dendritic cell expansion. [PDF]

Front Oncol
Gong J, Liu J, Lu L, Wei J, Wu X, Zou J, Feng Y, Zhu G, Han J.   +8 more
europepmc   +1 more source

Acute myeloid leukemia with t(10;17)(p15;q21)/ <i>ZMYND11::MBTD1</i>: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults. [PDF]

Haematologica
Wei Q, Pemmaraju N, Wang SA, Hu S, DiNardo C, Issa GC, Bueso-Ramos CE, Xu J, Li S, Medeiros JL, Tang G.   +10 more
europepmc   +1 more source

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Blood Adv
Khalife-Hachem S, Pages A, Akoury E, Bonnet S, Birsen R, Busquet C, Contejean A, Danu A, de Botton S, de Charette M, Dumas PY, Jaccard A, Marfaing-Koka A, Willekens C, Deconinck E, Ghez D.   +15 more
europepmc   +1 more source

SNPmanifold: detecting single-cell clonality and lineages from single-nucleotide variants using binomial variational autoencoder. [PDF]

Genome Biol
Chung HM, Huang Y.
europepmc   +1 more source

VPS34-IN1 potentiates STING-dependent activation in human CAL-1 cells. [PDF]

Cell Mol Biol Lett
Antas P, Machado MD, Leite-Pinheiro F, Barros D, Ramalhinho C, Mendes A, Ferreira BH, Carvoeiro D, Mendes LF, Reverendo M, Duarte IF, Narita M, Su B, Argüello RJ, Nal B, Pierre P, Almeida CR, Gatti E.   +17 more
europepmc   +1 more source

Advancing the understanding and management of blastic plasmacytoid dendritic cell neoplasm: Insights from recent case studies. [PDF]

World J Clin Cases
Luo Y, Wang LJ, Wang CL.
europepmc   +1 more source